{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:54:59Z","timestamp":1763535299424},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s10147-014-0773-4","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T19:57:40Z","timestamp":1417463860000},"page":"745-754","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hepatic arterial infusion chemotherapy with fine-powder cisplatin and iodized-oil suspension in patients with intermediate-stage and advanced-stage (Barcelona Clinic Liver Cancer stage-B or stage-C) hepatocellular carcinoma: multicenter phase-II clinical study"],"prefix":"10.1007","volume":"20","author":[{"given":"Haruyuki","family":"Takaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Yamakado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Tsurusaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Yasumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Narimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Shimohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norifumi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Anai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kakizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shozo","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,29]]},"reference":[{"key":"773_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69\u201390","journal-title":"CA Cancer J Clin"},{"key":"773_CR2","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142:1264\u20131273","journal-title":"Gastroenterology"},{"key":"773_CR3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1535-6108(04)00058-3","volume":"5","author":"J Bruix","year":"2004","unstructured":"Bruix J, Boix L, Sala M et al (2004) Focus on hepatocellular carcinoma. Cancer Cell 5:215\u2013219","journal-title":"Cancer Cell"},{"key":"773_CR4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V et al (2008) SHARP Investigators Study Group. Efficacy and safety of sorafenib in patients in the Asia\u2013Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. N Engl J Med 359:378\u2013390","journal-title":"N Engl J Med"},{"key":"773_CR5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","volume":"10","author":"AL Cheng","year":"2009","unstructured":"Cheng AL, Kang YK, Chen Z et al (2009) Efficacy and safety of sorafenib in patients in the Asia\u2013Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10:25\u201334","journal-title":"Lancet Oncol"},{"key":"773_CR6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000327577","volume":"29","author":"M Kudo","year":"2011","unstructured":"Kudo M, Izumi N, Kokudo N et al (2011) HCC Expert Panel of Japan Society of Hepatology. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 29:339\u2013364","journal-title":"Dig Dis"},{"key":"773_CR7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1872-034X.2012.01029.x","volume":"43","author":"T Yamashita","year":"2013","unstructured":"Yamashita T, Kaneko S (2013) Treatment strategies for hepatocellular carcinoma in Japan. Hepatol Res 43:44\u201350","journal-title":"Hepatol Res"},{"key":"773_CR8","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<1986::AID-CNCR2>3.0.CO;2-I","volume":"88","author":"YH Chung","year":"2000","unstructured":"Chung YH, Song IH, Song BC et al (2000) Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 88:1986\u20131991","journal-title":"Cancer"},{"key":"773_CR9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000112805","volume":"72","author":"M Ikeda","year":"2007","unstructured":"Ikeda M, Okusaka T, Ueno H et al (2007) Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis. Oncology 72:188\u2013193","journal-title":"Oncology"},{"key":"773_CR10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00432-010-0917-5","volume":"137","author":"BK Kim","year":"2011","unstructured":"Kim BK, Park JY, Choi HJ et al (2011) Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma. J Cancer Res Clin Oncol 137:659\u2013667","journal-title":"J Cancer Res Clin Oncol"},{"key":"773_CR11","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1007\/BF00686689","volume":"33","author":"M Yoshikawa","year":"1994","unstructured":"Yoshikawa M, Saisho H, Ebara M et al (1994) A randomized trial of intrahepatic arterial infusion of 4\u2032-epidoxorubicin with Lipiodol versus 4\u2032-epidoxorubicin alone in the treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol 33:S149\u2013S152","journal-title":"Cancer Chemother Pharmacol"},{"key":"773_CR12","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1872-034X.2008.00338.x","volume":"38","author":"M Yoshikawa","year":"2008","unstructured":"Yoshikawa M, Ono N, Yodono H et al (2008) Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma. Hepatol Res 38:474\u2013483","journal-title":"Hepatol Res"},{"key":"773_CR13","first-page":"4923","volume":"32","author":"T Beppu","year":"2012","unstructured":"Beppu T, Sugimoto K, Shiraki K et al (2012) Clinical utility of transarterial infusion chemotherapy using cisplatin\u2013lipiodol emulsion for unresectable hepatocellular carcinoma. Anticancer Res 32:4923\u20134930","journal-title":"Anticancer Res"},{"key":"773_CR14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00535-009-0109-8","volume":"45","author":"M Ikeda","year":"2010","unstructured":"Ikeda M, Maeda S, Ashihara H et al (2010) Transcatheter arterial infusion chemotherapy with cisplatin\u2013lipiodol suspension in patients with hepatocellular carcinoma. J Gastroenterol 45:60\u201367","journal-title":"J Gastroenterol"},{"key":"773_CR15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00280-009-1034-5","volume":"65","author":"Y Yamashita","year":"2010","unstructured":"Yamashita Y, Taketomi A, Itoh S et al (2010) Phase I\/II study of the lipiodolization using DDP-H (CDDP powder; IA-call(\u00ae)) in patients with unresectable hepatocellular carcinoma. Cancer Chemother Pharmacol 65:301\u2013307","journal-title":"Cancer Chemother Pharmacol"},{"key":"773_CR16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"773_CR17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2214\/ajr.168.3.9057522","volume":"168","author":"ME Tublin","year":"1997","unstructured":"Tublin ME, Dodd GD III, Baron RL (1997) Benign and malignant portal vein thrombosis: differentiation by CT characteristics. Am J Roentgenol 168:719\u2013723","journal-title":"Am J Roentgenol"},{"key":"773_CR18","first-page":"202","volume":"55","author":"Y Takaki","year":"2008","unstructured":"Takaki Y, Kaminou T, Shabana M et al (2008) Suitable blending method of lipiodol\u2013cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature. Hepatogastroenterology 55:202\u2013206","journal-title":"Hepatogastroenterology"},{"key":"773_CR19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"773_CR20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52\u201360","journal-title":"Semin Liver Dis"},{"key":"773_CR21","unstructured":"U.S. Department of Health and Human Service (2008) Common terminology criteria for adverse events (CTCAE). http:\/\/www.eortc.be\/services\/doc\/ctc\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf#search=\u2018CTCAE+v4\u2019 . Accessed Nov 2013"},{"key":"773_CR22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/jjco\/hyr037","volume":"41","author":"S Iwasa","year":"2010","unstructured":"Iwasa S, Ikeda M, Okusaka T et al (2010) Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolization. Jpn J Clin Oncol 41:770\u2013775","journal-title":"Jpn J Clin Oncol"},{"key":"773_CR23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jjco\/hyq145","volume":"41","author":"M Kondo","year":"2011","unstructured":"Kondo M, Morimoto M, Numata K et al (2011) Hepatic arterial infusion therapy with a fine powder formulation of cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Jpn J Clin Oncol 41:69\u201375","journal-title":"Jpn J Clin Oncol"},{"key":"773_CR24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00280-013-2222-x","volume":"72","author":"M Ikeda","year":"2013","unstructured":"Ikeda M, Okusaka T, Furuse J et al (2013) A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Cancer Chemother Pharmacol 72:463\u2013470","journal-title":"Cancer Chemother Pharmacol"},{"key":"773_CR25","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s00535-013-0853-7","volume":"49","author":"M Ikeda","year":"2014","unstructured":"Ikeda M, Mitsunaga S, Shimizu S et al (2014) Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization. J Gastroenterol 49:932\u2013940","journal-title":"J Gastroenterol"},{"key":"773_CR26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1148\/radiology.163.2.3031724","volume":"163","author":"K Takayasu","year":"1987","unstructured":"Takayasu K, Shima Y, Muramatsu Y et al (1987) Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 163:345\u2013351","journal-title":"Radiology"},{"key":"773_CR27","first-page":"775","volume":"13","author":"D Heresbach","year":"1989","unstructured":"Heresbach D, Raoul JL, Bentue-Ferrer D et al (1989) Chemotherapy combined with Lipiodol. In vitro study of the kinetics of release of adriamycin. Gastroenterol Clin Biol 13:775\u2013778","journal-title":"Gastroenterol Clin Biol"},{"key":"773_CR28","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiology.170.3.2536946","volume":"170","author":"H Nakamura","year":"1989","unstructured":"Nakamura H, Hashimoto T, Oi H et al (1989) Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170:783\u2013786","journal-title":"Radiology"},{"key":"773_CR29","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jvir.2011.03.005","volume":"22","author":"HT Hu","year":"2011","unstructured":"Hu HT, Kim JH, Lee LS et al (2011) Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort. J Vasc Interv Radiol 22:917\u2013923","journal-title":"J Vasc Interv Radiol"},{"key":"773_CR30","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s12072-011-9276-9","volume":"5","author":"Y-J Tsai","year":"2011","unstructured":"Tsai Y-J, Hsu C-Y, Huang Y-H et al (2011) Early identification of poor responders to transarterial chemoembolization for hepatocellular carcinoma. Hepatol Int 5:975\u2013984","journal-title":"Hepatol Int"},{"key":"773_CR31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ijc.20279","volume":"112","author":"SY Peng","year":"2004","unstructured":"Peng SY, Chen WJ, Lai PL et al (2004) High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer 112:44\u201350","journal-title":"Int J Cancer"},{"key":"773_CR32","author":"A Gramenzi","year":"2014","unstructured":"Gramenzi A, Golfieri R, Mosconi C et al (2014) Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis. Liver Int. doi: 10.1111\/liv.12574","journal-title":"Liver Int"},{"key":"773_CR33","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","volume":"57","author":"V Mazzaferro","year":"2013","unstructured":"Mazzaferro V, Sposito C, Bhoori S et al (2013) Yttrium-90 radioembolization for intermediate\u2013advanced hepatocellular carcinoma: a phase 2 study. Hepatology 57:1826\u20131837","journal-title":"Hepatology"},{"key":"773_CR34","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.23944","volume":"52","author":"P Hilgard","year":"2010","unstructured":"Hilgard P, Hamami M, Fouly AE et al (2010) Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology 52:1741\u20131749","journal-title":"Hepatology"},{"key":"773_CR35","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1245\/s10434-013-2906-9","volume":"20","author":"J Edeline","year":"2013","unstructured":"Edeline J, Lenoir L, Boudjema K et al (2013) Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting? Ann Surg Oncol 20:2518\u20132525","journal-title":"Ann Surg Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-014-0773-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-014-0773-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-014-0773-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:37:37Z","timestamp":1559126257000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-014-0773-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,29]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["773"],"URL":"https:\/\/doi.org\/10.1007\/s10147-014-0773-4","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,29]]}}}